PATHOBIOLOGY OF NEURODEGENERATION: THE ROLE FOR ASTROGLIA.

The common denominator of neurodegenerative diseases, which mainly affect humans, is the progressive death of neural cells resulting in neurological and cognitive deficits. Astroglial cells are the central elements of the homoeostasis, defence and regeneration of the central nervous system, and their malfunction or reactivity contribute to the pathophysiology of neurodegenerative diseases. Pathological remodelling of astroglia in neurodegenerative context is multifaceted. Both astroglial atrophy with a loss of function and astroglial reactivity have been identified in virtually all the forms of neurodegenerative disorders. Astroglia may represent a novel target for therapeutic strategies aimed at preventing and possibly curing neurodegenerative diseases.

[1]  A. Volterra,et al.  Focal degeneration of astrocytes in amyotrophic lateral sclerosis , 2008, Cell Death and Differentiation.

[2]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[3]  A. Verkhratsky,et al.  Sodium dynamics: another key to astroglial excitability? , 2012, Trends in Neurosciences.

[4]  E. Cattaneo,et al.  Huntington's disease. , 2014, Handbook of experimental pharmacology.

[5]  A. Verkhratsky,et al.  Pathologic Potential of Astrocytic Vesicle Traffic: New Targets to Treat Neurologic Diseases? , 2015, Cell transplantation.

[6]  S. Guénette.  Astrocytes: a cellular player in Abeta clearance and degradation. , 2003, Trends in molecular medicine.

[7]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[8]  A. Hazell,et al.  Loss of astrocytic glutamate transporters in Wernicke encephalopathy , 2010, Glia.

[9]  M. Mena,et al.  Glia conditioned medium protects fetal rat midbrain neurones in culture from L‐DOPA toxicity , 1996, Neuroreport.

[10]  A. Alzheimer.  Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .

[11]  A. Verkhratsky,et al.  Astrogliopathology: a central element of neuropsychiatric diseases? , 2014, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[12]  S V Faraone,et al.  Genetics of Alzheimer's disease. , 1996, Journal of the Formosan Medical Association = Taiwan yi zhi.

[13]  Maiken Nedergaard,et al.  Heterogeneity of astrocytic form and function. , 2012, Methods in molecular biology.

[14]  B. Hyman,et al.  Synchronous Hyperactivity and Intercellular Calcium Waves in Astrocytes in Alzheimer Mice , 2009, Science.

[15]  P. Maher,et al.  The Regulation of Glucose Metabolism by HIF-1 Mediates a Neuroprotective Response to Amyloid Beta Peptide , 2003, Neuron.

[16]  B. Strooper,et al.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.

[17]  E. Syková,et al.  Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer’s disease , 2012, Journal of anatomy.

[18]  T. Beach,et al.  Lamina-specific arrangement of astrocytic gliosis and senile plaques in Alzheimer's disease visual cortex , 1988, Brain Research.

[19]  K. Moore,et al.  Journal of Neuroinflammation BioMed Central , 2004 .

[20]  R. Terry.  Cell death or synaptic loss in Alzheimer disease. , 2000, Journal of neuropathology and experimental neurology.

[21]  A. Verkhratsky,et al.  Astrocytes in Alzheimer’s disease , 2010, Neurotherapeutics.

[22]  P. Emson,et al.  Glutamate Uptake is Reduced in Prefrontal Cortex in Huntington’s Disease , 2008, Neurochemical Research.

[23]  A. Mahal,et al.  Impaired Glutamate Uptake in the R6 Huntington's Disease Transgenic Mice , 2001, Neurobiology of Disease.

[24]  A. Verkhratsky,et al.  Translational potential of astrocytes in brain disorders , 2016, Progress in Neurobiology.

[25]  M. Tuszynski,et al.  Translational Neuroscience , 2016, Springer US.

[26]  G. Huntington,et al.  On Chorea , 1810, The Medical and physical journal.

[27]  Arnold Kriegstein,et al.  The glial nature of embryonic and adult neural stem cells. , 2009, Annual review of neuroscience.

[28]  Berislav V. Zlokovic,et al.  Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.

[29]  R. Tanzi,et al.  The Genetics of Alzheimer Disease: Back to the Future , 2010, Neuron.

[30]  R. Mrak,et al.  Glia and their cytokines in progression of neurodegeneration , 2005, Neurobiology of Aging.

[31]  a.R.V..  Neuroglia , 1956, Neurology.

[32]  Ammonium Increases Ca2+ Signalling and Up-Regulates Expression of TRPC1 Gene in Astrocytes in Primary Cultures and in the In Vivo Brain , 2014, Neurochemical Research.

[33]  C. Iadecola,et al.  Glial regulation of the cerebral microvasculature , 2007, Nature Neuroscience.

[34]  Alexei Verkhratsky,et al.  Glial calcium signalling in Alzheimer's disease. , 2014, Reviews of physiology, biochemistry and pharmacology.

[35]  Milos Pekny,et al.  The dual role of astrocyte activation and reactive gliosis , 2014, Neuroscience Letters.

[36]  B. Barres,et al.  Astrocyte heterogeneity: an underappreciated topic in neurobiology , 2010, Current Opinion in Neurobiology.

[37]  R. Castellani,et al.  Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is ‘too big to fail’ , 2011, The Journal of pathology.

[38]  H Bratzke,et al.  Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. , 1998, Progress in brain research.

[39]  Pierre J Magistretti,et al.  Amyloid-β Aggregates Cause Alterations of Astrocytic Metabolic Phenotype: Impact on Neuronal Viability , 2010, The Journal of Neuroscience.

[40]  A. Verkhratsky,et al.  Amyloid-β and Alzheimer's disease type pathology differentially affects the calcium signalling toolkit in astrocytes from different brain regions , 2013, Cell Death and Disease.

[41]  S. Wesselingh,et al.  Correlation between neurological progression and astrocyte apoptosis in HIV‐associated dementia , 2001, Annals of neurology.

[42]  R. Armstrong.  The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer's disease. , 2009, Folia neuropathologica.

[43]  V. Bigl,et al.  Neuronal and glial β‐secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology , 2001, Journal of neuroscience research.

[44]  A. Troncoso,et al.  Regional differences in astrocyte activation in HIV-associated dementia. , 2006, Medicina.

[45]  Alexei Verkhratsky,et al.  Ca2+‐dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid β‐treated astrocytes and in a model of Alzheimer's disease , 2013, Aging cell.

[46]  R. Tanzi.  The genetics of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[47]  Ji-Yeon Shin,et al.  Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity , 2005, The Journal of cell biology.

[48]  Randy F. Stout,et al.  Glial cells in (patho)physiology , 2012, Journal of neurochemistry.

[49]  M. Maier,et al.  Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia , 2013, European Archives of Psychiatry and Clinical Neuroscience.

[50]  Joseph B. Martin.  Huntington's disease , 1984, Neurology.

[51]  John Hardy,et al.  The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal , 2009, Journal of neurochemistry.

[52]  A. Verkhratsky,et al.  Glial physiology and pathophysiology , 2013 .

[53]  M. Mena,et al.  Glial Cells as Players in Parkinsonism: The “Good,” the “Bad,” and the “Mysterious” Glia , 2008, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[54]  J. Mostert,et al.  Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders , 2008, Journal of the Neurological Sciences.

[55]  D. Rossi,et al.  The multifaceted role of glial cells in amyotrophic lateral sclerosis , 2013, Cellular and Molecular Life Sciences.

[56]  A. Verkhratsky,et al.  Pathological Role for Exocytotic Glutamate Release from Astrocytes in Hepatic Encephalopathy , 2014, Current neuropharmacology.

[57]  Milos Pekny,et al.  Glia in the pathogenesis of neurodegenerative diseases. , 2014, Biochemical Society transactions.

[58]  G. Rajkowska,et al.  Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue. , 2013, Current drug targets.

[59]  A. Volterra,et al.  Astrocytic dysfunction: Insights on the role in neurodegeneration , 2009, Brain Research Bulletin.

[60]  P. Baron,et al.  Glial activation in Alzheimer’s disease: the role of Aβ and its associated proteins , 2001, Neurobiology of Aging.

[61]  Santiago Canals,et al.  The role of astroglia on the survival of dopamine neurons , 2002, Molecular Neurobiology.

[62]  A. Verkhratsky,et al.  Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease , 2011, ASN neuro.

[63]  T. Takano,et al.  Astrocyte-mediated control of cerebral blood flow , 2006, Nature Neuroscience.

[64]  Yan Ao,et al.  Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice , 2014, Nature Neuroscience.

[65]  Ben A. Barres,et al.  Emerging roles of astrocytes in neural circuit development , 2013, Nature Reviews Neuroscience.

[66]  M. Nedergaard,et al.  Artifact versus reality—How astrocytes contribute to synaptic events , 2012, Glia.

[67]  A. Messing.  Alexander disease. , 2018, Handbook of clinical neurology.

[68]  P. Kalivas,et al.  Astrocytic Dysfunction and Addiction , 2014, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[69]  Why are Astrocytes Important? , 2015, Neurochemical Research.

[70]  W. Griffin,et al.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[71]  M. Sofroniew,et al.  Neurological diseases as primary gliopathies: a reassessment of neurocentrism , 2012, ASN neuro.

[72]  M. Pekny,et al.  The Neurobiology of Brain Injury , 2012, Cerebrum : the Dana forum on brain science.

[73]  Carlos Cepeda,et al.  Full-Length Human Mutant Huntingtin with a Stable Polyglutamine Repeat Can Elicit Progressive and Selective Neuropathogenesis in BACHD Mice , 2008, The Journal of Neuroscience.

[74]  M. Asanuma,et al.  Striatal Astrocytes Act as a Reservoir for L-DOPA , 2014, PloS one.

[75]  Maiken Nedergaard,et al.  Astroglial cradle in the life of the synapse , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[76]  A. Verkhratsky,et al.  Astroglia in neurological diseases. , 2013, Future neurology.

[77]  A. Verkhratsky,et al.  Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer's disease , 2010, Glia.

[78]  T. Wyss-Coray,et al.  Adult mouse astrocytes degrade amyloid-β in vitro and in situ , 2003, Nature Medicine.

[79]  A. Verkhratsky,et al.  Homeostatic function of astrocytes: Ca2+ and Na+ signalling , 2012, Translational neuroscience.

[80]  D. Gutmann,et al.  Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice. , 2011, Human molecular genetics.

[81]  A. Korczyn.  The amyloid cascade hypothesis , 2008, Alzheimer's & Dementia.

[82]  B. Barres,et al.  Genomic Analysis of Reactive Astrogliosis , 2012, The Journal of Neuroscience.

[83]  J. Brioni,et al.  and Alzheimer's disease , 2010 .

[84]  C. Rose,et al.  Dysbalance of Astrocyte Calcium under Hyperammonemic Conditions , 2014, PloS one.

[85]  A. Verkhratsky,et al.  Glial Asthenia and Functional Paralysis , 2015, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[86]  C. Rose,et al.  Ammonium‐evoked alterations in intracellular sodium and pH reduce glial glutamate transport activity , 2009, Glia.

[87]  H. Zoghbi,et al.  Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.

[88]  D. Gutmann,et al.  Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis , 2008, Nature Neuroscience.

[89]  A. Verkhratsky,et al.  Memory Formation Shaped by Astroglia , 2015, Front. Integr. Neurosci..

[90]  M. Sofroniew,et al.  Reactive Gliosis and the Multicellular Response to CNS Damage and Disease , 2014, Neuron.

[91]  E. Benarroch,et al.  Microglia , 2013, Methods in Molecular Biology.

[92]  K. Lindenberg,et al.  Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. , 2002, Brain : a journal of neurology.

[93]  M. Kaul,et al.  Mechanisms of neuronal injury and death in HIV-1 associated dementia. , 2006, Current HIV research.

[94]  M. C. Angulo,et al.  Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation , 2003, Nature Neuroscience.

[95]  A. Hazell.  Astrocytes are a major target in thiamine deficiency and Wernicke's encephalopathy , 2009, Neurochemistry International.

[96]  Alberto Pupi,et al.  Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's Disease , 2008, Annals of the New York Academy of Sciences.

[97]  F. Saravia,et al.  Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease , 2013, Experimental Neurology.

[98]  M. Guillermier,et al.  In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects , 2010, Human molecular genetics.

[99]  R. Castellani,et al.  Alzheimer disease. , 2010, Disease-a-month : DM.

[100]  A. Verkhratsky,et al.  The glial perspective of autism spectrum disorders , 2014, Neuroscience & Biobehavioral Reviews.

[101]  M. Nedergaard,et al.  Functions of astrocytes and their potential as therapeutic targets , 2010, Neurotherapeutics.

[102]  B. MacVicar,et al.  Calcium transients in astrocyte endfeet cause cerebrovascular constrictions , 2004, Nature.

[103]  Michael T. Heneka,et al.  Neuroglia in neurodegeneration , 2010, Brain Research Reviews.

[104]  Manoj K. Gottipati,et al.  Enhanced Ca2+-dependent glutamate release from astrocytes of the BACHD Huntington's disease mouse model , 2013, Neurobiology of Disease.

[105]  R. Weller,et al.  A new role for astrocytes: β-amyloid homeostasis and degradation , 2003 .

[106]  W. Penfield.  Cytology & cellular pathology of the nervous system , 1965 .

[107]  S. Roßner,et al.  Alzheimer's disease β‐secretase BACE1 is not a neuron‐specific enzyme , 2005 .

[108]  K. Staats,et al.  Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival , 2009, Journal of biological physics.

[109]  M. Sofroniew,et al.  Astrocytes: biology and pathology , 2009, Acta Neuropathologica.

[110]  Jose Julio Rodriguez,et al.  Astroglia in dementia and Alzheimer's disease , 2009, Cell Death and Differentiation.

[111]  M. Malcangio.  Glia , 2018, Oxford Medicine Online.

[112]  R. Schliebs,et al.  Aging-related down-regulation of neprilysin, a putative β-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of β-amyloid plaques , 2003, Neuroscience Letters.

[113]  A. Verkhratsky,et al.  Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders , 2016, Neurobiology of Disease.

[114]  M. D'Andrea,et al.  Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains , 2003, Brain Research.